期刊文献+

实体器官移植受者侵袭性真菌病的临床治疗管理

Clinical treatment and management of invasive fungal disease in recipients of solid organ transplantation
下载PDF
导出
摘要 随着实体器官移植(SOT)的广泛开展,SOT受者术后侵袭性真菌病(IFD)的发生率呈逐年上升趋势。近年来,对于SOT受者预防性抗真菌治疗意识不断增强,随之也出现了真菌耐药问题,导致原有标准化抗真菌治疗的效果不理想。而药物相互作用、药物的肝肾毒性等问题,也是临床医师需面对的挑战。本文综述了目前三唑类、棘白菌素类以及多烯类抗真菌药物与免疫抑制药之间的药物相互作用和肝肾毒性等特征,并总结了目前不同种类SOT受者术后IFD的预防策略以及感染不同病原体导致IFD的治疗策略,旨在为器官移植及相关学科的医师提供参考。 With widespread application of solid organ transplantation(SOT),the incidence of postoperative invasive fungal disease(IFD)in SOT recipients has been increased year by year.In recent years,the awareness of preventive antifungal therapy for SOT recipients has been gradually strengthened.However,the problem of fungal resistance has also emerged,leading to unsatisfactory efficacy of original standardized antifungal regimens.Drug-drug interaction and hepatorenal toxicity induced by drugs are also challenges facing clinicians.In this article,the characteristics of drug-drug interaction and hepatorenal toxicity among triazole,echinocandin and polyene antifungal drugs and immunosuppressants were reviewed,and postoperative preventive strategies for IFD in different types of SOT recipients and treatment strategies for IFD caused by infection of different pathogens were summarized,aiming to provide reference for physicians in organ transplantation and related disciplines.
作者 Arnoux Robenson Jean 周佩军 Arnoux Robenson Jean;Zhou Peijun(Department of Urology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)
出处 《器官移植》 CSCD 北大核心 2024年第1期151-159,共9页 Organ Transplantation
基金 上海市保健医疗科研课题(202240032)。
关键词 实体器官移植 侵袭性真菌病 药物相互作用 抗真菌治疗 药物浓度监测 侵袭性假丝酵母病 侵袭性曲霉病 耶氏肺孢子菌肺炎 Solid organ transplantation Invasive fungal disease Drug-drug interaction Antifungal therapy Drug concentration monitoring Invasive candidiasis Invasive aspergillosis Pneumocystis jiroveci pneumonia
  • 相关文献

参考文献20

二级参考文献173

  • 1两性霉素B脱氧胆酸盐临床合理应用专家共识编写组,中国医药教育协会感染疾病专业委员会,中华医学会细菌感染与耐药防控专业委员会,俞云松,刘又宁,王明贵,冯靖,黄英姿,黄志伟,李昕,王俊,吴波,许利军,杨青,张俊丽,周华,周志慧,朱剑萍.两性霉素B脱氧胆酸盐临床合理应用专家共识(2022)[J].中华医学杂志,2023,103(16):1173-1183. 被引量:9
  • 2乔锦昌.卡氏肺孢子虫病一例误诊报告[J].临床误诊误治,2005,18(4):240-241. 被引量:1
  • 3尹玉琴,刘勇,徐贵丽,张云玲.药物相互作用对环孢素A血药浓度的影响[J].中国药事,2006,20(6):378-379. 被引量:8
  • 4<应用抗菌药物防治外科感染的指导意见>撰写协作组,王春生,陈昊.应用抗菌药物防治外科感染的指导意见(草案)ⅩⅧ——临床心脏移植感染的预防与治疗[J].中华外科杂志,2006,44(22):1563-1564. 被引量:3
  • 5高楠,许春舫,陈卫昌.肝硬化合并新型隐球菌脑膜炎一例[J].中华消化杂志,2006,26(11):787-787. 被引量:2
  • 6Saito T,See S,Kanda Y,et al.Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.Am J Hematol.2001 ;67(3):206-209.
  • 7Orlando G,Tariciotti L,Manzia TM,et al.Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia.Transpl Infect Dis.2010;12(1):11-15.
  • 8Teshale EH,Hanson DL,Wolfe MI,et al.Reasons for lack of appropriate receipt of primary Pneumocystis jiroveci pneumonia prophylaxis among HIV-infected persons receiving treatment in the United States:1994-2003.Clin Infect Dis.2007;44(6):879-883.
  • 9Haidinger M,Hecking M,Memarsadeghi M,et al.Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept.Transpl Infect Dis.2009; 11(2):171-174.
  • 10Chuu WM,Catlett JP,Perry DJ,et al.Concurrent Pneumocystis carinii and cytomegalovirus pneumonia after autologous peripheral blood stem cell transplantation.Bone Marrow Transplant.1999;23(10):1087-1089.

共引文献304

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部